Patients desire improved treatments, voters call for safety, biomed startups want drug approval to continue in business and big pharma is after big profits. The Food and Drug Administration must grapple with these issues, which are only getting more complex. Dr. Steve Galson, director of the FDA’s Center for Drug Evaluation and Research, took the stage at the Dow Jones VentureWire Health Care Innovations 2006 in Redwood City, California, on September 12th, 2006. In this keynote interview Galson tells interviewer Brian Gormley — associate editor of the Dow Jones publication Venture Capital Analyst —what is on the mind of the FDA lately.
Tags: Food and Drug Administration, Steve Galson, Brian Gormley
Press:
pr@podtech.net
Sales:
sales@podtech.net
Feedback:
feedback@podtech.net
PodTech Network is committed to protecting your online privacy while providing you with the most useful and enjoyable Web experience possible.
Copyright ©2008 PodTech.net. All rights reserved. Modified: Sun, 07 Sep 2008 15:43:43 -0700